BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8116930)

  • 1. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
    Li DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
    Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K
    Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors.
    Park JG; Reddy EP
    Oncogene; 1992 Aug; 7(8):1603-9. PubMed ID: 1630821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
    Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
    Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined erbB gene overexpression and decreased H-ras gene expression in human gliomas.
    Patt S; Cervós-Navarro J
    Acta Histochem Suppl; 1992; 42():131-8. PubMed ID: 1584958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biological properties of hamster tumor cell lines transformed with B77 virus: expression of v-src does not correlate with metastatic potential.
    Kisseleva NP; Sabová L; Weismanová E
    Neoplasma; 1991; 38(3):293-301. PubMed ID: 1713304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogenes of genomic DNA in clinically normal animals of various species.
    Miyoshi N; Tateyama S; Ogawa K; Nosaka D; Ohashi T; Sunyasootcharee B
    Am J Vet Res; 1991 Jun; 52(6):940-4. PubMed ID: 1883100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of myb expression in an aggressive SJL/J B-cell lymphoma.
    Sopchak L; Thrush GR; Lerman SP; King SR
    Oncogene; 1991 Aug; 6(8):1335-8. PubMed ID: 1886709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
    Jin Y; Burns FJ; Garte SJ
    Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
    Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
    Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J
    Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
    Husain Z; FitzGerald GB; Wick MM
    J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
    Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
    Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
    Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
    Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.